Birchview Capital, LP’s Cytokinetics Inc Position
Does Birchview Capital, LP own Cytokinetics Inc (CYTK)? Yes — 30.0K shares worth $2M (+1.13% of its 13F portfolio) as of Q1 2026.
Position Value
$2M
Q1 2026
Shares
30.0K
% of Portfolio
+1.13%
Quarters Held
24
currently held
Position History CYTK
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 30.0K | $2M | +1.13% |
| Q4 2025 | 30.0K | $2M | +1.12% |
| Q3 2025 | 30.0K | $2M | +1.24% |
| Q2 2025 | 10.0K | $330,400 | +0.33% |
| Q1 2025 | 10.0K | $401,900 | +0.35% |
| Q4 2024 | 10.0K | $470,400 | +0.38% |
| Q3 2024 | 10.0K | $528,000 | +0.46% |
| Q2 2024 | 10.0K | $541,800 | +0.50% |
| Q1 2024 | 10.0K | $701,100 | +0.57% |
| Q4 2023 | 25.0K | $2M | +1.64% |
| Q3 2023 | 25.0K | $736,500 | +0.63% |
| Q2 2023 | 25.0K | $815,500 | +0.61% |
| Q1 2023 | 25.0K | $880 | +0.69% |
| Q4 2022 | 25.0K | $1,146 | +0.81% |
| Q3 2022 | 25.0K | $1M | +0.85% |
| Q2 2022 | 25.0K | $982,000 | +0.71% |
| Q1 2022 | 25.0K | $920,000 | +0.66% |
| Q4 2021 | 25.0K | $1M | +0.74% |
| Q3 2021 | 25.0K | $894,000 | +0.61% |
| Q2 2021 | 10.0K | $198,000 | +0.12% |
| Q3 2019 | 10.0K | $114,000 | +0.08% |
| Q2 2019 | 10.0K | $113,000 | +0.07% |
| Q1 2019 | 10.0K | $81,000 | +0.05% |
| Q4 2018 | 10.0K | $63,000 | +0.06% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Birchview Capital, LP’s full portfolio or all institutional holders of CYTK.